Literature DB >> 34353323

A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.

Melissa Perri1,2, Natalie Kaminski1,3, Matthew Bonn3,4, Gillian Kolla5, Adrian Guta6, Ahmed M Bayoumi2,7,8,9, Laurel Challacombe10, Marilou Gagnon5, Natasha Touesnard3, Patrick McDougall11, Carol Strike12,13.   

Abstract

BACKGROUND: Spotting is an informal practice among people who use drugs (PWUD) where they witness other people using drugs and respond if an overdose occurs. During COVID-19 restrictions, remote spotting (e.g., using a telephone, video call, and/or a social media app) emerged to address physical distancing requirements and reduced access to harm reduction and/or sexually transmitted blood borne infection (STBBI's) prevention services. We explored spotting implementation issues from the perspectives of spotters and spottees.
METHODS: Research assistants with lived/living expertise of drug use used personal networks and word of mouth to recruit PWUD from Ontario and Nova Scotia who provided or used informal spotting. All participants completed a semi-structured, audio-recorded telephone interview about spotting service design, benefits, challenges, and recommendations. Recordings were transcribed and thematic analysis was used.
RESULTS: We interviewed 20 individuals between 08/2020-11/2020 who were involved in informal spotting. Spotting was provided on various platforms (e.g., telephone, video calls, and through texts) and locations (e.g. home, car), offered connection and community support, and addressed barriers to the use of supervised consumption sites (e.g., location, stigma, confidentiality, safety, availability, COVID-19 related closures). Spotting calls often began with setting an overdose response plan (i.e., when and who to call). Many participants noted that, due to the criminalization of drug use and fear of arrest, they preferred that roommates/friends/family members be called instead of emergency services in case of an overdose. Both spotters and spottees raised concerns about the timeliness of overdose response, particularly in remote and rural settings.
CONCLUSION: Spotting is a novel addition to, but not replacement for, existing harm reduction services. To optimize overdose/COVID-19/STBBI's prevention services, additional supports (e.g., changes to Good Samaritan Laws) are needed. The criminalization of drug use may limit uptake of formal spotting services.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Digital; Digital health interventions; Harm reduction; Overdose prevention; Spotting

Year:  2021        PMID: 34353323     DOI: 10.1186/s12954-021-00530-3

Source DB:  PubMed          Journal:  Harm Reduct J        ISSN: 1477-7517


  8 in total

1.  Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: A proof-of-concept study in a real-world setting.

Authors:  Alexis M Roth; Nguyen K Tran; Ben Cocchiaro; Allison K Mitchell; David G Schwartz; Devon J Hensel; Janna Ataiants; Jacob Brenner; Inbal Yahav; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2021-10-28       Impact factor: 4.492

2.  Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.

Authors:  Fiona N Conway; Jake Samora; Katlyn Brinkley; Haelim Jeong; Nina Clinton; Kasey R Claborn
Journal:  Harm Reduct J       Date:  2022-07-02

Review 3.  The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.

Authors:  Sameer Imtiaz; Frishta Nafeh; Cayley Russell; Farihah Ali; Tara Elton-Marshall; Jürgen Rehm
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-11-29

4.  Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts.

Authors:  Abeed Sarker; Nisha Nataraj; Wesley Siu; Sabrina Li; Christopher M Jones; Steven A Sumner
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-03-05

5.  Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.

Authors:  Thomas D Brothers; Malcolm Leaman; Matthew Bonn; Dan Lewer; Jacqueline Atkinson; John Fraser; Amy Gillis; Michael Gniewek; Leisha Hawker; Heather Hayman; Peter Jorna; David Martell; Tiffany O'Donnell; Helen Rivers-Bowerman; Leah Genge
Journal:  Drug Alcohol Depend       Date:  2022-04-07       Impact factor: 4.852

6.  COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.

Authors:  Melissa Perri; Rose A Schmidt; Adrian Guta; Nat Kaminski; Katherine Rudzinski; Carol Strike
Journal:  Int J Drug Policy       Date:  2022-08-08

7.  Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.

Authors:  Andrew Ivsins; Laura MacKinnon; Jeanette M Bowles; Amanda Slaunwhite; Geoff Bardwell
Journal:  J Urban Health       Date:  2022-08-31       Impact factor: 5.801

8.  Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island.

Authors:  Alexandria Macmadu; Annajane Yolken; Lisa Frueh; Jai'el R Toussaint; Roxxanne Newman; Brendan P Jacka; Alexandra B Collins; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2022-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.